AKAtsuko Kurosaki

Atsuko Kurosaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Atsuko Kurosaki has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuma Kishi

    Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan

    2 shared publications
  • Sakae Homma

    Department of Respiratory Medicine Toho University Omori Medical Center Tokyo Japan

    2 shared publications
  • Aika Suzuki

    Department of Respiratory Medicine, Toho University Graduate School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo 143-8541, Japan

    1 shared publication
  • Akihiro Ishizu

    Department of Medical Laboratory Science, Faculty of Health Sciences Hokkaido University Sapporo Japan

    1 shared publication
  • Atsushi Miyamoto

    Department of Respiratory Medicine, Respiratory Centre, Toranomon Hospital, Tokyo, Japan

    1 shared publication
  • Hiroaki Dobashi

    Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan

    1 shared publication

Latest Publications

  • Differences in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis

    by Yusuke Usui, Susumu Sakamoto, Sakae Homma, Atsuko Kurosaki, Yasuyuki Kurihara, Keita Sato, Aika Suzuki, Toshihiro Nanki, Yoshihiro Arimura, Seiichi Matsuo, et al.

  • Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis

    by Tomohiro Handa, Kiminobu Tanizawa, Tsuyoshi Oguma, Ryuji Uozumi, Kizuku Watanabe, Naoya Tanabe, Takafumi Niwamoto, Hiroshi Shima, Ryobu Mori, Tomomi W. Nobashi, et al.

    Rationale: There is a growing need to accurately estimate the prognosis of idiopathic pulmonary fibrosis (IPF) in clinical practice, given the development of effective drugs for treating IPF. Objectives: To develop artificial intelligence-based image analysis software to detect parenchymal and airway abnormalities on computed tomographic (CT) imaging of the chest and to explore their prognostic importance in patients with IPF. Methods: A novel artificial intelligence-based quantitative CT image analysis software (AIQCT) was developed by applying 304 high-resolution CT (HRCT) scans from patients with diffuse lung diseases as the training set. AIQCT automatically categorized and quantified 10 types of parenchymal patterns as well as airways, expressing the volumes as percentages of the total lung volume. To validate the software, the area percentages of each lesion quantified by AIQCT were compared with those of the visual scores using 30 plain high-resolution CT images with lung diseases. In addition, three-dimensional analysis for similarity with ground truth was performed using HRCT images from 10 patients with IPF. AIQCT was then applied to 120 patients with IPF who underwent HRCT scanning of the chest at our institute. Associations between the measured volumes and survival were analyzed. Results: The correlations between AIQCT and the visual scores were moderate to strong (correlation coefficient 0.44–0.95) depending on the parenchymal pattern. The Dice indices for similarity between AIQCT data and ground truth were 0.67, 0.76, and 0.64 for reticulation, honeycombing, and bronchi, respectively. During a median follow-up period of 2,184 days, 66 patients died, and 1 underwent lung transplantation. In multivariable Cox regression analysis, bronchial volumes (adjusted hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.16–1.53) and normal lung volumes (adjusted HR, 0.97; 95% CI, 0.94–0.99) were independently associated with survival after adjusting for the gender-age-lung physiology stage of IPF. Conclusions: Our newly developed artificial intelligence-based image analysis software successfully quantified parenchymal lesions and airway volumes. Bronchial and normal lung volumes on HRCT imaging of the chest may provide additional prognostic information on the gender-age-lung physiology stage of IPF.


  • HRCT features of surgically resected invasive mucinous adenocarcinoma associated with interstitial pneumonia

    by Atsushi Miyamoto, Atsuko Kurosaki, Takeshi Fujii, Kazuma Kishi, Sakae Homma

    Background and objective: Lung cancer is prevalent among patients with interstitial pneumonia (IP). HRCT findings mucinous adenocarcinoma in patients with IP have not been described.Methods: In 112 consecutive patients with 120 surgically resected IP‐associated lung cancers, 42 patients had pathologically proven invasive adenocarcinoma (IA). A total of 14 out of 42 patients (10 men, 4 women, mean age, 68.4 years) had invasive mucinous adenocarcinoma. We reviewed the patients’ medical records and HRCT scans.Results: Invasive mucinous adenocarcinoma were most commonly associated with idiopathic IP (n = 13) affecting the lower lobe adjacent to a fibrocystic changes. In 11 patients with invasive mucinous adenocarcinoma or other types of IA, the tumour was adjacent to a fibrocystic lesion. In invasive mucinous adenocarcinoma, malignant signs included lobulation (n = 11), spiculation (n = 9), vascular convergence (n = 10) and pleural indentation (n = 2). Characteristic findings of mucinous adenocarcinoma (i.e. vague margins (n = 10), lobular‐bounded margins (n = 11), air bronchogram (n = 11) and bubble‐like low attenuation (n = 8)) were more common in invasive mucinous adenocarcinoma than in other IA types. All invasive mucinous adenocarcinoma tumours (n = 11) were closely associated with fibrosis.Conclusion: Mixed ground‐glass opacity and consolidation adjacent to a fibrocystic lesion with malignant signs and characteristic features of mucinous adenocarcinoma indicate malignancy.